Most ladies are aware of mammography as our “gold standard” for breast cancer screening. Nevertheless, you can get further tools available that girls are able to add to their arsenal.
One of several best tools in breast cancer screening is breast self exam (BSE). However, BSE works best when females are correctly trained in the procedure, and then followed up with annual clinical breast exams (CBE) from the physicians of theirs. In a 2000 University of Toronto study, about 20,000 females happened to be screened for breast cancer with BSE and annual CBE, and 20,000 were screened with BSE and mammograms. After at least 10 years, the BSE and annual CBE reported 610 cases of invasive breast cancer, and 105 deaths. In the BSE and mammogram group, there were 622 cases of invasive breast cancer and 107 deaths. Wthout a doubt, the original line of defense against breast cancer starts with diligent BSE.
Other tools that are available to females include the AMAS (anti-malignan antibody screen) test and the NMP Nuclear matrix protein) test. Both these are blood tests that measure a specific protein in the blood which may indicate cancer. The AMAS test has existed for a few years while the NMP test hasn’t been available until merely recently. Clinical trials continue in this area.
One additional tool which can detect an issue early on is digital infrared thermal imaging or DITI. In 1982, the FDA approved thermography as an adjunctive tool for breast cancer screening. DITI measures heat emitted from the body and is accurate to 1/100th of a degree. Physiology is examined by DITI, NOT structure. It’s in this capacity that DITI can monitor breast HEALTH over time and alert a patient or even physician to a developing problem; possibly before a lump could be seen on X ray or perhaps palpated clinically. There won’t be any test limitations such as breast density. DITI is a non-invasive test which doesn’t emit radiation.
The distinctive characteristics of DITI is allowed by cancer to detect breast cancer at an earlier stage of growth. As cancer is developing, it builds a blood supply and that is then reflected as increased heat in that specific region of the breast. DITI has a specificity of eighty three %; which reflects a problem in its first stages of development not late-stage cancer as in mammography. An abnormal thermogram carries a 10-times greater risk for cancer and a persistently abnormal thermogram carries a 22 times greater risk for cancer.
Recommended–> : https://www.nuprobe.com
Medical research studies continue to support thermography’s role as an adjunctive tool in breast cancer screening and also the ONLY tool that measures breast health over time. These day there are over 800 publications on over 300,000 ladies in clinical trials. A recent finding published in the American Journal of Radiology in 2003 showed that thermography has ninety nine % sensitivity in identifying breast cancer with single examinations and limited views. Scientists concluded that a negative thermogram is powerful evidence that cancer is not really present.